Reed Harris was appointed as Advisory Board at BIOADAPTIVES, INC..
“On February 6, 2025, the Company appointed Mr. Reed Harris to its Advisory Board.”
BIOADAPTIVES, INC. — fact timeline
Source-grounded facts extracted from BIOADAPTIVES, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Mark Frissora was appointed as Board of Directors at BIOADAPTIVES, INC..
“On February 3, 2025 , the Company appointed Mr. Mark Frissora to its Board of Directors.”
BIOADAPTIVES, INC. engaged Boladale Lawal & Co as its auditor.
“BioAdaptives’ Board approved the appointment of Boladale Lawal & Co as the Company’s new independent registered PCAOB firm”
BIOADAPTIVES, INC. dismissed BF Borgers, CPA PC as its auditor.
“Changes in Registrant's PCAOB Auditing Firm ITEM 304(a)(1) Dismissal of Independent PCAOB Auditing firm, BF Borgers On May 8 2024, the Board of Directors of BioAdaptives Inc (the “Company”) approved the dismissal of BF Borgers, CPA PC (“BFB”) as the Company's independent registered auditing firm.”
BIOADAPTIVES, INC.: Amended Articles of Incorporation to increase authorized shares of common stock from 750,000,000 to 1,250,000,000 shares and authorize 10,000,000 preferred shares (effective 2023-03-27).
“On March 6, 2023, the Company’s board and a majority of its shareholders approved an amendment to the Company’s Articles of Incorporation to increase the authorized number of shares of its common stock, par value .0001, from 750,000,000 shares to 1,250,000,000 shares of which 10,000,000 may be preferred shares. The increase became effective March 27, 2023.”
Dr. Yaguang Liu was appointed as Board of Directors at BIOADAPTIVES, INC..
“On April 5, 2023, the Company appointed Dr. Yaguang Liu to its Board of Directors.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.